Chen et al. found that forced expression of miR-18a could downregulate IRF-2 expression and inhibit P53 expression, indicating that IRF-2 could serve as a tumor suppressor by regulating P53 signaling in gastric cancer [17]. The gene discussed is TP53; the disease is neoplasm.